← Back to patent-cliff list
tamsulosin
Tier C — Watch / tradetamsulosin
Gl Pharm Tech Corp
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：ADRA1A
Indications (approved)：输尿管支架相关症状, Urinary retention, 输尿管结石, Kidney stones, Benign prostatic hyperplasia
Regional status
US
Phase III
2025-02-03
EU
-
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of tamsulosin?
Approved indications include: 输尿管支架相关症状, Urinary retention, 输尿管结石, Kidney stones, Benign prostatic hyperplasia.
When does the tamsulosin patent expire?
No public expiry year is available for tamsulosin yet; this page updates once verified.
How do I get a quote for tamsulosin intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-06